Risk Factors for Postoperative Pneumonia: A Case-Control Study.

outcomes pathogen distribution perioperative postoperative pneumonia risk factors

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 06 04 2022
accepted: 20 06 2022
entrez: 25 7 2022
pubmed: 26 7 2022
medline: 27 7 2022
Statut: epublish

Résumé

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and outcomes of postoperative pneumonia. A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in China. Cases included all patients developing postoperative pneumonia within 30 days after surgery, defined using consensus criteria. Controls were selected randomly from the matched eligible population. Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged ventilation, and longer duration of bed rest were identified as significant risk factors independently associated with postoperative pneumonia. Regarding prognostic implications, postoperative pneumonia was associated with longer length of hospital stay, higher ICU occupancy rate, higher unplanned re-operation rate, and higher in-hospital mortality rate. Postoperative pneumonia was most commonly caused by Gram-negative pathogens, and multidrug resistant bacteria accounted for approximately 16.99% of cases. Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative pneumonia, and the distribution of causative pathogens can also help in the implementation of effective interventions. www.chictr.org.cn, identifier: chiCTR2100045986.

Sections du résumé

Background
Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and outcomes of postoperative pneumonia.
Methods
A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in China. Cases included all patients developing postoperative pneumonia within 30 days after surgery, defined using consensus criteria. Controls were selected randomly from the matched eligible population.
Results
Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged ventilation, and longer duration of bed rest were identified as significant risk factors independently associated with postoperative pneumonia. Regarding prognostic implications, postoperative pneumonia was associated with longer length of hospital stay, higher ICU occupancy rate, higher unplanned re-operation rate, and higher in-hospital mortality rate. Postoperative pneumonia was most commonly caused by Gram-negative pathogens, and multidrug resistant bacteria accounted for approximately 16.99% of cases.
Conclusions
Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative pneumonia, and the distribution of causative pathogens can also help in the implementation of effective interventions.
Clinical Trial Registration
www.chictr.org.cn, identifier: chiCTR2100045986.

Identifiants

pubmed: 35875004
doi: 10.3389/fpubh.2022.913897
pmc: PMC9304902
doi:

Banques de données

ChiCTR
['chiCTR2100045986']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

913897

Informations de copyright

Copyright © 2022 Xiang, Jiao, Si, Yao, Yuan and Chen.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Surg. 2006 Feb;191(2):216-24
pubmed: 16442949
JAMA Surg. 2013 Aug;148(8):740-5
pubmed: 23740240
Surg Today. 2016 May;46(5):552-6
pubmed: 26077287
Lancet. 2008 Jul 12;372(9633):139-144
pubmed: 18582931
Medicine (Baltimore). 2020 Jun 26;99(26):e20836
pubmed: 32590774
Int J Chron Obstruct Pulmon Dis. 2016 Nov 09;11:2785-2796
pubmed: 27877032
J Surg Res. 2015 Jan;193(1):77-87
pubmed: 25260955
Br J Anaesth. 2018 May;120(5):1066-1079
pubmed: 29661384
BMC Pulm Med. 2018 Jan 9;18(1):4
pubmed: 29316890
J Trauma Acute Care Surg. 2015 May;78(5):912-8; discussion 918-9
pubmed: 25909409
Eur J Anaesthesiol. 2019 Feb;36(2):93-104
pubmed: 30431500
Arch Cardiol Mex. 2016 Jul-Sep;86(3):203-7
pubmed: 26949195
Int J Surg. 2013;11(6):467-71
pubmed: 23602896
Curr Opin Anaesthesiol. 2014 Apr;27(2):201-9
pubmed: 24419159
PLoS One. 2019 Mar 18;14(3):e0214083
pubmed: 30883602
Lancet Respir Med. 2015 Jan;3(1):33-41
pubmed: 25523407
Br J Anaesth. 2017 Aug 01;119(2):249-257
pubmed: 28854546
Curr Opin Crit Care. 2015 Aug;21(4):322-7
pubmed: 26126130
Gen Thorac Cardiovasc Surg. 2021 Jan;69(1):84-90
pubmed: 32914386
J Bone Joint Surg Am. 2017 Dec 20;99(24):2110-2118
pubmed: 29257017
JAMA. 2011 Aug 24;306(8):848-55
pubmed: 21862746
Nat Hum Behav. 2018 Jan;2(1):5
pubmed: 30980055
Surg Neurol Int. 2013;4:24
pubmed: 23532567
Int J Clin Oncol. 2016 Oct;21(5):920-926
pubmed: 27173949
Surg Today. 2020 May;50(5):460-468
pubmed: 31712912
BMJ. 2010 Jun 21;340:c2608
pubmed: 20566596

Auteurs

Bingbing Xiang (B)

Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Department of Anesthesiology, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.

Shulan Jiao (S)

Department of Anesthesiology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Yongyu Si (Y)

Department of Anesthesiology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Yuting Yao (Y)

Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Feng Yuan (F)

Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Department of Anesthesiology, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.

Rui Chen (R)

Geriatric Diseases Institute of Chengdu/Cancer Prevention and Treatment Institute of Chengdu, Department of Anesthesiology, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH